ZipLine Medical said today that it raised a $9 million funding round for its surgical skin closure line.

The round was led by existing backer MVM Life Science Partners, joined by HighCape Partners and Bridge Bank. Campbell, Calif.-based said it plans to use the proceeds to commercialize the Zip closure portfolio and to back the launch of its ZipStitch and PreLoc products.

“This financing provides ZipLine Medical with additional capital to continue our strong revenue growth in the U.S. and internationally. We are excited about the strong market acceptance of our Zip surgical skin closure devices in many surgical specialties, including orthopedics, cardiovascular, and the emergency department,” president & CEO John Tighe said in prepared remarks.

“The ZipLine team continues to introduce innovative products based on proven core technology that address the needs of new markets, and we are proud to be a part of this,” added MVM partner Bali Muralidhar.

A year ago ZipLine closed a $12 million Series E round.